South Korea's CD BIO Seeks Clinical Trial, FDA Registration for Its VOCs Biosensing Kit That Detects Early Stage Lung and Other Cancers With Simple Breathing Test
September 05, 2022 09:01 ET
|
CD BIO
LOS ANGELES, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Korean technicians announced on the 30th that they have developed a diagnostic device that diagnoses lung cancer from breathing tests. They have plans...